Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica N McAlpine

Showing results (71-80 of 186) with videos related to

Pageof 19
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 19, 2026
Co-Existent Endometrial and Fallopian Tube Carcinoma, Molecular and Pathological Features for Risk StratificationKianoosh Keyhanian, C Blake Gilks, Elizabath Priya Mathew, et al.
Plos One|July 19, 2014
Absence of BRCA/FMR1 correlations in women with ovarian cancersNorbert Gleicher, Jessica N McAlpine, C Blake Gilks, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 21, 2017
Survival Benefit of Adjuvant Radiotherapy: An Analysis of Low-Stage Invasive Ovarian Mucinous CarcinomasAalok Kumar, Nhu Le, C Blake Gilks, et al.
Journal of Translational Medicine|December 5, 2021
From biobank and data silos into a data commons: convergence to support translational medicineRebecca Asiimwe, Stephanie Lam, Samuel Leung, et al.
Histopathology|September 30, 2015
Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapySalwa Bakhsh, Mary Kinloch, Lien N Hoang, et al.
The American Journal of Surgical Pathology|July 16, 2014
Expanding the morphologic spectrum of differentiated VIN (dVIN) through detailed mapping of cases with p53 lossNaveena Singh, Sarah L Leen, Guangming Han, et al.
Histopathology|August 15, 2023
Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtypeJutta Huvila, Emily F Thompson, Jamie Vanden Broek, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 2, 2023
Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing ProtocolAline Talhouk, Amy Jamieson, Emma J Crosbie, et al.
Cancer|October 18, 2024
Challenges in implementation of molecular classification in early stage endometrial cancer-An NRG Oncology cooperative group mixed-methods studyElise M Wilson, Ruizhi Huang, Kristen D Jones, et al.
Human Pathology|September 4, 2025
Assessment of Nectin4-Expression in Vulvar Squamous Cell Carcinomas (VSCC): correlation with HPV-associated and HPV-independent Molecular SubtypesAnne Kathrin Höhn, Grit Gesine Ruth Hiller, Benjamin Wolf, et al.
Pageof 19

Showing results (71-80 of 186) with videos related to

Sort By:
Pageof 19
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 19, 2026
Co-Existent Endometrial and Fallopian Tube Carcinoma, Molecular and Pathological Features for Risk StratificationKianoosh Keyhanian, C Blake Gilks, Elizabath Priya Mathew, et al.
Plos One|July 19, 2014
Absence of BRCA/FMR1 correlations in women with ovarian cancersNorbert Gleicher, Jessica N McAlpine, C Blake Gilks, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 21, 2017
Survival Benefit of Adjuvant Radiotherapy: An Analysis of Low-Stage Invasive Ovarian Mucinous CarcinomasAalok Kumar, Nhu Le, C Blake Gilks, et al.
Journal of Translational Medicine|December 5, 2021
From biobank and data silos into a data commons: convergence to support translational medicineRebecca Asiimwe, Stephanie Lam, Samuel Leung, et al.
Histopathology|September 30, 2015
Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapySalwa Bakhsh, Mary Kinloch, Lien N Hoang, et al.
The American Journal of Surgical Pathology|July 16, 2014
Expanding the morphologic spectrum of differentiated VIN (dVIN) through detailed mapping of cases with p53 lossNaveena Singh, Sarah L Leen, Guangming Han, et al.
Histopathology|August 15, 2023
Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtypeJutta Huvila, Emily F Thompson, Jamie Vanden Broek, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 2, 2023
Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing ProtocolAline Talhouk, Amy Jamieson, Emma J Crosbie, et al.
Cancer|October 18, 2024
Challenges in implementation of molecular classification in early stage endometrial cancer-An NRG Oncology cooperative group mixed-methods studyElise M Wilson, Ruizhi Huang, Kristen D Jones, et al.
Human Pathology|September 4, 2025
Assessment of Nectin4-Expression in Vulvar Squamous Cell Carcinomas (VSCC): correlation with HPV-associated and HPV-independent Molecular SubtypesAnne Kathrin Höhn, Grit Gesine Ruth Hiller, Benjamin Wolf, et al.
Pageof 19